179 related articles for article (PubMed ID: 31340678)
1. Zinc oxide end-capped Fe
Liu M; Sun X; Liao Z; Li Y; Qi X; Qian Y; Fenniri H; Zhao P; Shen J
Drug Deliv; 2019 Dec; 26(1):732-743. PubMed ID: 31340678
[TBL] [Abstract][Full Text] [Related]
2. Calcium carbonate end-capped, folate-mediated Fe
Liu MC; Liu B; Chen XL; Lin HC; Sun XY; Lu JZ; Li YY; Yan SQ; Zhang LY; Zhao P
J Biomater Appl; 2018 Mar; 32(8):1090-1104. PubMed ID: 29357775
[TBL] [Abstract][Full Text] [Related]
3. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
Zhang J; Wu D; Li MF; Feng J
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
[TBL] [Abstract][Full Text] [Related]
5. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
Small; 2017 Jan; 13(2):. PubMed ID: 27735129
[TBL] [Abstract][Full Text] [Related]
6. Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.
Wang W; Wang Y; Wang Y; Gong H; Zhu H; Liu M
IET Nanobiotechnol; 2019 Aug; 13(6):640-649. PubMed ID: 31432799
[TBL] [Abstract][Full Text] [Related]
7. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
8. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
[TBL] [Abstract][Full Text] [Related]
9. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
[TBL] [Abstract][Full Text] [Related]
10. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
11. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
[TBL] [Abstract][Full Text] [Related]
12. Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.
Abedi M; Abolmaali SS; Abedanzadeh M; Farjadian F; Mohammadi Samani S; Tamaddon AM
Int J Nanomedicine; 2020; 15():2617-2631. PubMed ID: 32368044
[TBL] [Abstract][Full Text] [Related]
13. A dual-targeting Fe
Liu X; Wang C; Wang X; Tian C; Shen Y; Zhu M
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111455. PubMed ID: 33255040
[TBL] [Abstract][Full Text] [Related]
14. Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery.
He Y; Wang C; Wu Q; Zhang G
Nanotechnology; 2024 May; 35(31):. PubMed ID: 38657569
[TBL] [Abstract][Full Text] [Related]
15. pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery.
Cai X; Luo Y; Zhang W; Du D; Lin Y
ACS Appl Mater Interfaces; 2016 Aug; 8(34):22442-50. PubMed ID: 27463610
[TBL] [Abstract][Full Text] [Related]
16. Supercritically dried superparamagnetic mesoporous silica nanoparticles for cancer theranostics.
Vaz-Ramos J; Cordeiro R; Castro MMCA; Geraldes CFGC; Costa BFO; Faneca H; Durães L
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111124. PubMed ID: 32600723
[TBL] [Abstract][Full Text] [Related]
17. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia.
Tao C; Zhu Y
Dalton Trans; 2014 Nov; 43(41):15482-90. PubMed ID: 25190592
[TBL] [Abstract][Full Text] [Related]
18. Formation of oligonucleotide-gated silica shell-coated Fe₃O₄-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform.
Li WP; Liao PY; Su CH; Yeh CS
J Am Chem Soc; 2014 Jul; 136(28):10062-75. PubMed ID: 24953310
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Field-Induced Accentuation of Drug Release from Core/Shell Magnetic Mesoporous Silica Nanoparticles for Anticancer Treatment.
Knezević Nikola Z
J Nanosci Nanotechnol; 2016 Apr; 16(4):4195-9. PubMed ID: 27451786
[TBL] [Abstract][Full Text] [Related]
20. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
